GREAT POINT PARTNERS LLC
CIK 1281446
13F filing for Q2 2026・No. 3,768
- Holdings
- US$529.12M
- Quarter change
- +US$94M
- Entries
- 42
- Net bought (estimate)
- −US$24.78M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 11
- Sold out 13
- Cut 9
- Added 7
- Corporate actions 0
- Unchanged 10
Largest holdings
37 stocks worth US$424.45M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| VOR BIOPHARMA INCCOM NEW | Cut | 1,700,000 | US$31.3M | 7.37% |
| ABIVAX SASPONSORED ADS | New | 204,314 | US$27.23M | 6.41% |
| VERA THERAPEUTICS INCCL A | Added | 600,836 | US$25.78M | 6.07% |
| ZURA BIO LTDCLASS A ORD SHS | Unchanged | 4,215,930 | US$24.87M | 5.86% |
| ALUMIS INCCOM | Unchanged | 856,061 | US$24.09M | 5.68% |
| SOL-GEL TECHNOLOGIES LTDSHS NEW | Unchanged | 274,363 | US$20.34M | 4.79% |
| DFTXDEFINIUM THERAPEUTICS INCCOM SHS | New | 425,000 | US$19.99M | 4.71% |
| ANNEXON INCCOM | Added | 3,500,000 | US$19.99M | 4.71% |
| ORUKA THERAPEUTICS INCCOM | Unchanged | 183,330 | US$17.45M | 4.11% |
| MOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD | Added | 855,813 | US$16.66M | 3.93% |
Sign in (free) to see its 37 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.